Peter C. Farrell - Oct 2, 2024 Form 4 Insider Report for RESMED INC (RMD)

Role
Director
Signature
Peter C. Farrell, Chairman emeritus
Stock symbol
RMD
Transactions as of
Oct 2, 2024
Transactions value $
-$474,400
Form type
4
Date filed
10/2/2024, 04:20 PM
Previous filing
Sep 6, 2024
Next filing
Nov 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale -$474K -2K -2.29% $237.20 85.2K Oct 2, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan adopted May 28, 2024